Auxo Firm Directory · Independent Research Profile

Advent International

Advent International describes a global private equity platform focused on partnering with management teams to drive operational improvement and sustainable value creation. Its published criteria span multiple investment programs and include equity investments from $50m–$2b, depending on the program.

Key takeaway

What stands out about Advent International

Advent International publicly targets business and financial services, consumer, healthcare, industrial, and technology opportunities. Its published programs accommodate different investment sizes and enterprise values, while its stated transaction capabilities include equity deals, leveraged buyouts, complex carve-outs, and public-to-private transactions.[1][2][3][6][7][8]

What does Advent International invest in?

Advent International is a global private equity investor founded in Boston in 1984. Advent states that it invests in companies and partners with management teams to drive operational improvement, meaningful progress, and sustainable value creation.

The firm describes a global platform combining in-market and sub-sector specialization with global reach. Its stated experience includes working with multinational organizations, family-owned businesses, and entrepreneurs.[1][2]

Advent describes an approach built around in-market and sub-sector specialization, global reach, rigorous diligence, and collaborative value-creation planning. It combines in-market and sub-sector specialization with global reach to source investments with potential to achieve scale, and it states that it partners with management teams to drive operational improvement and sustainable value creation.

Advent also states that it can pursue equity deals, leveraged buyouts, complex carve-outs, and public-to-private transactions. Its published strategy emphasizes flexibility across these transaction types.[1][2][3]

Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.

Public size / criteria information
Published program criteria include GPE X equity investments of $/€100m–$/€2b in companies with enterprise value up to $/€5b and select larger transactions; Advent Tech II equity investments of $50m–$2b in companies with $200m–$5b enterprise value and select larger transactions; and LAPEF VII equity investments of $50m–$300m in companies with $200m–$1b enterprise value and select larger transactions.[2]

What should a business owner evaluate before considering a transaction with Advent International?

An owner evaluating Advent can compare the company’s scale and sector characteristics with its published program parameters. The published materials also indicate flexibility across equity investments, leveraged buyouts, complex carve-outs, and public-to-private transactions.

Advent’s recent announcements show majority, significant minority, consortium, and primary-capital structures. Owners should clarify the ownership percentage, governance rights, rollover expectations, management autonomy, leverage approach, operational resources, international expansion plans, investment horizon, exit approach, contracting entity, and any regulatory conditions for a proposed transaction.[2][3][5][6][7][8]

01

What ownership percentage and governance rights would Advent seek for a business of this size and sector

Advent’s recent public announcements include a significant minority investment and a majority-shareholding agreement, alongside other transaction structures.[5][6]
02

How much founder or management rollover would be expected

Advent has publicly described transactions in which existing shareholders, management, and other shareholders retain minority ownership.[6]
03

Which Advent fund or program would invest, and which equity and enterprise-value parameters would apply

Advent publishes distinct criteria for GPE X, Advent Tech II, and LAPEF VII, including different equity-investment and enterprise-value ranges.[2]

What companies does Advent International target?

Advent’s published investment programs specify different equity-investment and enterprise-value parameters. GPE X states typical Advent equity investments of $/€100m–$/€2b for companies with enterprise value up to $/€5b, with select larger transactions.

Advent Tech II states an equity-investment range of $50m–$2b for companies with $200m–$5b enterprise value, with select larger transactions. LAPEF VII states an equity-investment range of $50m–$300m for companies with $200m–$1b enterprise value, with select larger transactions.[2]

Advent identifies five core sectors: business and financial services, consumer, healthcare, industrial, and technology.

Representative sub-sector areas cited by Advent include payments, cybersecurity, chemicals, luxury goods and beauty, pharmaceuticals, and other technology-enabled areas.[3]

Advent states that it has people on the ground in 17 offices in 14 countries across five continents. Its public materials describe activity across North America, Latin America, Europe, Asia, and other developed and emerging markets.

Advent’s global-reach page reports more than 130 North American investments, more than 70 Latin American investments, and more than 200 European investments.[3][4]

The sources cited for this profile do not establish a platform-versus-add-on model.

Advent’s official Investments page lists Japan Wellbeing Corp., Avio, Quantum Systems, Reflection AI, and Stark among its newest investment entries dated June or July 2026.[9]

  • On September 17, 2026, Advent announced a definitive agreement to invest Rs 3,150 crore of primary capital in Yatharth Hospitals for an expected 24.9% significant minority stake, subject to customary closing conditions.
  • On August 20, 2026, Advent announced a definitive agreement to acquire a majority shareholding in NZCR Group, while clinician shareholders, management, and Waterman Capital retain a significant minority shareholding.
  • On August 4, 2026, Advent and a consortium including HarbourVest Partners agreed to acquire FNZ Bank from FNZ, subject to customary regulatory and other approvals.
  • On June 25, 2026, Advent announced a definitive agreement to acquire Japan Wellbeing Corp. from MBK Partners, marking Advent’s first investment in Japan.
[5][6][7][8]

What is not clear from Advent International's public investment criteria?

The cited NZCR Group transaction announcement states that the transaction terms were not disclosed. The cited Japan Wellbeing Corp. transaction announcement likewise states that the transaction terms were not disclosed.

The cited FNZ Bank transaction announcement does not state transaction consideration or ownership percentages and states that completion is subject to customary regulatory and other approvals.[6][7][8]

Questions to ask when evaluating Advent International as a buyer or investment partner

What ownership percentage and governance rights would Advent seek for a business of this size and sector?
Advent’s recent public announcements include a significant minority investment and a majority-shareholding agreement, alongside other transaction structures.[5][6]
How much founder or management rollover would be expected?
Advent has publicly described transactions in which existing shareholders, management, and other shareholders retain minority ownership.[6]
Which Advent fund or program would invest, and which equity and enterprise-value parameters would apply?
Advent publishes distinct criteria for GPE X, Advent Tech II, and LAPEF VII, including different equity-investment and enterprise-value ranges.[2]
What operational resources and specific Portfolio Support Group or Operating Partner capabilities would be assigned?
Advent states that it partners with management teams to drive operational improvement.[2]
How would Advent approach add-on acquisitions, international expansion, leverage, and management incentives?
Advent publicly states that it can pursue leveraged buyouts and combines global reach with sub-sector specialization.[1][3]
What is the expected investment horizon and exit approach for the proposed transaction?
The question addresses transaction planning for an owner evaluating a potential capital partnership.
Which Advent legal entity would be the contracting or investing entity, and what regulatory approvals or conditions would apply?
Advent identifies regulated entities in Luxembourg, the United Kingdom, and Hong Kong, and its FNZ Bank announcement refers to customary regulatory and other approvals.[7][10][11]

Sources & research notes

Public-source research
  1. Official website / firm overview
  2. Services / capabilities
  3. Investment approach
  4. Geography / market coverage
  5. Transaction / portfolio evidence
  6. Transaction / portfolio evidence
  7. Transaction / portfolio evidence
  8. Transaction / portfolio evidence
  9. Transaction / portfolio evidence
  10. Structure / regulatory context
  11. SEC investment adviser record
Prepared and reviewed by: Auxo Capital AdvisorsEvidence standard: Public-source verification

How this profile was researched

Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.

Independent profile & regulatory context

Independent research profile

This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.

Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.

Broker-dealer and securities disclosure

Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.

Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.

Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.

Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.